Top

Chinese Medicine

Published in:

Open Access 01-12-2022 | COVID-19 | Review

Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis

Authors: Xinxin Wang, Tao Ma, Wei Zhang, Qiang Chu

Published in: Chinese Medicine | Issue 1/2022

Abstract

Background

Since the outbreak of COVID-19 in 2019, the global economy, culture, politics, and people's lives and health have been severely damaged and threatened. Although western modern medical treatment has made great efforts, the treatment of COVID-19 has not achieved ideal clinical efficacy with severe sequelae. Qingfei Paidu (QFPD), an important herbal prescription for COVID-19 treatment, has shown remarkable therapeutic effects in China's fight against the epidemic.

Materials and methods

We searched seven databases up to 7 September 2022, including PubMed, Chinese National Knowledge Infrastructure (CNKI), Wanfang Database, Cochrane Central Register of Controlled Trials (CENTRAL), EMBASE, World Scientific and SpringerLink. We used the Cochrane Risk of Bias tool to assess the quality of randomized controlled trials. All analysis results were conducted by RevMan 5.4.1 to carry out a meta-analysis.

Results

Fifteen studies with 10390 patients were included. QFPD could not only significantly improve the cure rate and lung CT of COVID-19, reduce the number of patients turning to critical condition and death, shorten the time for nucleic acid conversion and the length of hospital stay, but change laboratory indexes and relieve body symptoms quickly without adverse effects.

Conclusions

Compared with patients only treated by conventional western treatment (CWM), QFPD combined with CWM could be more effective for patients. It is worth spreading to other countries in the global battle against COVID-19.

WHO. Coronavirus disease (COVID-19) pandemic, 2022. https://covid19.who.int/.

Hu XM, Geng LM, Guo DZ, et al. Analysis and observation of modified Qingfei Paidu decoction in patients with COVID-19. Hebei J TCM. 2020;42:1605–9. https://doi.org/10.3969/j.issn.1002-2619.2020.11.001.CrossRef

Wang RQ, Yang SJ, Xie CG, et al. Clinical observation of Qingfeipaidu decoction in the treatment of COVID-19. Pharmacol Clin Chin Mater. 2020;36(1):13–8. https://doi.org/10.13412/j.cnki.zyyl.20200303.002.CrossRef

Meng JH, He Y, Chen Q, et al. A retrospective study on the treatment of COVID-19 type common/type severe with Qingfei Paidu decoction. Chin J Hosp Pharm. 2020;40:2152–7. https://doi.org/10.13286/j.1001-5213.2020.20.12.CrossRef

Shi M, Hou Y, Zhou H, et al. Clinical observation of Qingfei Paidu decoction on 47 cases of COVID-19. World Latest Med Inf. 2021;21(40):223–4. https://doi.org/10.3969/j.issn.1671-3141.2021.40.106.CrossRef

Dai ZQ, Jiang SH, Liu T, et al. Novel coronavirus Pneumonia treated by QingfeiPaidu decoction: a clinical analysis of 36 cases. J GuiZhou Univ Tradit Chin Med. 2021;42(6):34–8. https://doi.org/10.16588/j.cnki.issn2096-8426.2020.06.007.CrossRef

Wang EC, Tang L, Xu K, et al. Efficacy evaluation of Qingfeipaidu decoction in the treatment of 75 cases of mild and common type of COVID-19 with enzymatic index. Pharm Clin Chin Mater Med. 2020;11(1):3–5.

Li CB, Yun SU, Liu YQ, et al. Traditional Chinese medicine theory and modern pharmacology of Qingfei Paidu decoction. J Tradit Chin Med. 2020;61(15):1299–302. https://doi.org/10.13288/j.11-2166/r.2020.15.003.CrossRef

Zhou MQ, Yang LP, Ma HJ, et al. Network pharmacological study of Qingfei Paidu decoction intervening on cytokine storm mechanism of COVID-19. J Hainan Med Coll. 2020;26(10):721–9. https://doi.org/10.13210/j.cnki.jhmu.20200507.003.CrossRef

10.

Xu TF, He CG, Yang K. Network pharmacology-based study on material basis and mechanism of Qingfei Paidu decoction against COVID-19. Nat Prod Res Dev. 2020;32:901–8.

11.

Wang Q, Zhu HF, Li ML, et al. Efficacy and safety of Qingfei Paidu decoction for treating COVID-19: a systematic review and meta-analysis. Front Pharmacol. 2021. https://doi.org/10.3389/fphar.2021.688857.CrossRefPubMedPubMedCentral

12.

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.CrossRefPubMedPubMedCentral

13.

Higgins, J. P. T., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M. J., et al. (2021). Cochrane Handbook for Systematic Reviews of Interventions Version 6.2 (Accessed on February 2021). Cochrane. www.training.cochrane.org/handbook.

14.

Wang Y, Chen L, Zheng L, et al. Clinical effects of Qingfei Paidu decoction combined with conventional treatment on patients with coronavirus disease. Chin Traditi Patent Med. 2020;43(3):656–9. https://doi.org/10.3969/j.issn.1001-1528.2021.03.017.CrossRef

15.

Geng LM, Guo DZ, Yan HQ, et al. Clinical characteristics of 75 patients with COVID-19 in Hebei province and the effect of Qingfei Paidu decoction: a retrospective analysis. Hebei J TCM. 2022;44(06):918–22+948.

16.

Wells,G.A., Shea,B., O’connell, D.,Peterson,J., Welch,V., Losos,L., et al. (2012). The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses .Department of Epidemiology and Community Medicine, University of Ottawa, Canada. University of Ottawa, Canada. Available at: www.ohri.ca/ programs/clinical_epidemiology/oxford.asp (Online Accessed 25 Jan 2021).

17.

Li KY, An W, Xia F, et al. Observation on clinical effect of modified Qingfeipaidu decoction in treatment of COVID-19. Chin Tradit Herbal Drugs. 2020;51(8):2046–9. https://doi.org/10.7501/j.issn.0253-2670.2020.08.008.CrossRef

18.

Li YD, Zhang WJ. Evaluation on the clinical effect of traditional chinese medicine and Western medicine regimens on COVID-19. CJGMCM. 2020;35(9):1273–5. https://doi.org/10.3969/j.issn.1003-8914.2020.09.001.CrossRef

19.

Sun TF. Qingfei PaiDu Decoction for viral pneumonia, Database of Chinese sci-tech journals, 2020:50–51.

20.

Xin SY, Cheng XQ, Zhu B, et al. Clinical retrospective study on the efficacy of Qingfei Paidu decoction combined with Western medicine for COVID-19 treatment. Biomed Pharmacother. 2020;129(110500):1–8. https://doi.org/10.1016/j.biopha.2020.110500.CrossRef

21.

Yu HY, Reng XH, Qi XX, et al. Efficacy study of Arbidol, Qingfei Paidu decoction, Lianhuaqingwen capsule, and Jinye Baidu granules in the treatment of mild/moderate COVID-19 in a Fangcang shelter hospital. Pharm Clin Chin Mater Med. 2020;6:3–13. https://doi.org/10.13412/j.cnki.zyyl.20201110.005.CrossRef

22.

Zhang P, Pan GT. Clinical Study on the Improvement of Inflammatory Cytokines in Critically III Patients with COVID-19 Treated by Qingfei Paidu Decoction. World Sci Technol Mod Tradit Chin Med. 2020;23(2):391–4. https://doi.org/10.11842/wst.20200416003.CrossRef

23.

Liu Z, Du S, Shao F, et al. Efficacy of Qingfei Paidu decoction on patients with COVID-19 pneumonia in Wuhan China: a propensity score matching study. Evid Based Complement Altern Med. 2021. https://doi.org/10.1155/2021/4303380.CrossRef

24.

Zeng XH, Ma WH, Wang J, et al. Effect of Qingfei Paidu decoction on clinical efficacy of COVID-19 pneumonia with phlegm heat blocking lung. Med J West China. 2020;32(12):1799–806. https://doi.org/10.3969/j.issn.1672-3511.2020.12.017.CrossRef

25.

Wang QL, Sun LF, Zhao MF, et al. The application effect of Qingfei Paidu decoction in the treatment of patients with COVID-19 with the syndrome of deficiency of both Qi and Yin. Acta Chin Med. 2021;36(5):910–4. https://doi.org/10.16368/j.issn.1674-8999.2021.05.192.CrossRef

26.

Yu XY, et al. Comparison of clinical efficacy of Qingfei Paidu decoction combined with western medicine in 43 cases and single western medicine in 46 cases in the treatment of COVID-19. J Shandong Univ (Health Sci). 2020;58(12):47–52. https://doi.org/10.6040/j.issn.1671-7554.0.2020.0870.CrossRef

27.

Zhang LH, Zheng X, Bai XK, et al. Association between use of Qingfei Paidu Tang and mortality in hospitalized patients with COVID-19: a national retrospective registry study. Phytomedicine. 2021;85(153531):2–8. https://doi.org/10.1016/J.PHYMED.2021.153531.CrossRef

28.

Xu TL, Zhou X, Chen XF, et al. The clinical application and efficacy of traditional chinese medicine COVID-19 patients in Jiangxi province. J Jiangxi Univ TCM. 2020;32(3):27–33.

29.

Yang M, Sun ZP, Liu J. Analysis of therapeutic effect of Qingfei Paidu Decoction combined with α-interferon in the treatment of COVID-19. Shenzhen J Integ Tradit Chin West Med. 2022;30(8):29–30.

30.

Wang Q, Li KW, Zhou CZ. Progress in pharmacological effect and preparation of Luteolin. J Beijing Union Univ. 2022;36(1):59–62. https://doi.org/10.16255/j.cnki.ldxbz.2022.01.009.CrossRef

31.

Xu HX, Lee SF. Activity of plant flavonoils against antibiotic resistant bacteria. Phytother Res. 2001;15(1):39–43. https://doi.org/10.1002/1099-1573(200102)15:1%3c39::aid-ptr684%3e3.0.co;2-r.CrossRefPubMed

32.

Zhao J, Tian SS, Yang J, et al. Investigating the mechanism of Qing-Fei-Pai-Du-Tang for the treatment of Novel Coronavirus Pneumonia by network pharmacology. Chin Tradit Herbal Drugs. 2020;4:2–8. https://doi.org/10.7501/j.issn.0253-2670.2020.04.001.CrossRef

33.

COVID-19 Diagnosis and Treatment Protocol (Trial Version 9), General Office of the National Health Commission, Office of the National Administration of Traditional Chinese Medicine,http://www.nhc.gov.cn/yzygj/s7653p/202203/b74ade1ba4494583805a3d2e40093d88.shtml, 2022–3–15, 1–8.

34.

Wang X, Wang WQ, Liu JM, et al. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. Med Res Methodol. 2014;14:1–13. https://doi.org/10.1186/1471-2288-14-135.CrossRef

35.

Luo DH, Wan X, Liu JM, et al. Optimally estimating the sample mean from the sample size, median, mid-range and/or mid-quartile range. Stat Methods Med Res. 2018;27:1785–805. https://doi.org/10.1177/0962280216669183.CrossRefPubMed

36.

Singh S, Sharma A, Monga V, et al. Compendium of naringenin: potential sources, analytical aspects, chemistry, nutraceutical potentials and pharmacological profile. Crit Rev Food Sci Nutr. 2022;38:1–32. https://doi.org/10.1080/10408398.2022.2056726.CrossRef

37.

Wu H, Wang JQ, Yang YW, et al. Preliminary exploration of the mechanism of Qingfei Paidu decoction against novel coronavirus pneumonia based on network pharmacology and molecular docking technology. Acta Pharmaceutica Sinica. 2020;55(3):374–83. https://doi.org/10.16438/j.0513-4870.2020-0136.CrossRef

38.

Zhang ZQ, Zhu SX. Research progress on pharmacological activities and clinical application of quercetin. J Pharmaceutica Res. 2013;32(7):400–3.

39.

Zhao J, Tian SS, Lu D, et al. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19. Phytomedicine. 2021;85:153315. https://doi.org/10.1016/j.phymed.2020.153315.CrossRefPubMed

Title: Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis
Authors: Xinxin Wang
Tao Ma
Wei Zhang
Qiang Chu
Publication date: 01-12-2022
Publisher: BioMed Central
Keyword: COVID-19
Published in: Chinese Medicine / Issue 1/2022
Electronic ISSN: 1749-8546
DOI: https://doi.org/10.1186/s13020-022-00675-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Effectiveness and safety research of Qingfei Paidu (QFPD) in treatment of COVID-19: an up-to-date systematic review and meta-analysis

Abstract

Background

Materials and methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Materials and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

Dicoumarol: from chemistry to antitumor benefits

Clinical and economic analysis of Gastrodin injection for dizziness or vertigo: a retrospective cohort study based on electronic health records in China

Identification of potential immunomodulators from Pulsatilla decoction that act on therapeutic targets for ulcerative colitis based on pharmacological activity, absorbed ingredients, and in-silico molecular docking

CRISPR-Cas gene editing technology and its application prospect in medicinal plants

An anti-inflammatory and anti-fibrotic proprietary Chinese medicine nasal spray designated as Allergic Rhinitis Nose Drops (ARND) with potential to prevent SARS-CoV-2 coronavirus infection by targeting RBD (Delta)- angiotensin converting enzyme 2 (ACE2) binding

Chemometrics integrated with in silico pharmacology to reveal antioxidative and anti-inflammatory markers of dandelion for its quality control